BDBM50126574 CHEMBL35813::N-[(S)-1-(3-Bromo-phenyl)-ethyl]-2-[3-(4-carbamimidoyl-3-fluoro-phenyl)-ureido]-acetamide
SMILES: C[C@H](NC(=O)CNC(=O)Nc1ccc(C(N)=N)c(F)c1)c1cccc(Br)c1
InChI Key: InChIKey=CVCMDSPOHSKOKC-JTQLQIEISA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coagulation factor VII (Homo sapiens (Human)) | BDBM50126574 (CHEMBL35813 | N-[(S)-1-(3-Bromo-phenyl)-ethyl]-2-[...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | 120 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH Curated by ChEMBL | Assay Description In vitro inhibitory activity against coagulation factor VII (fVIIa) | Bioorg Med Chem Lett 13: 1463-7 (2003) BindingDB Entry DOI: 10.7270/Q2Q52P1B | |||||||||||
More data for this Ligand-Target Pair |